IDEAS home Printed from https://ideas.repec.org/a/nat/nature/v510y2014i7504d10.1038_nature13229.html
   My bibliography  Save this article

Therapeutic targeting of BET bromodomain proteins in castration-resistant prostate cancer

Author

Listed:
  • Irfan A. Asangani

    (Michigan Center for Translational Pathology, University of Michigan Medical School
    University of Michigan Medical School)

  • Vijaya L. Dommeti

    (Michigan Center for Translational Pathology, University of Michigan Medical School)

  • Xiaoju Wang

    (Michigan Center for Translational Pathology, University of Michigan Medical School
    University of Michigan Medical School)

  • Rohit Malik

    (Michigan Center for Translational Pathology, University of Michigan Medical School
    University of Michigan Medical School)

  • Marcin Cieslik

    (Michigan Center for Translational Pathology, University of Michigan Medical School)

  • Rendong Yang

    (Emory University)

  • June Escara-Wilke

    (Michigan Center for Translational Pathology, University of Michigan Medical School)

  • Kari Wilder-Romans

    (University of Michigan Medical School)

  • Sudheer Dhanireddy

    (Michigan Center for Translational Pathology, University of Michigan Medical School)

  • Carl Engelke

    (Michigan Center for Translational Pathology, University of Michigan Medical School)

  • Mathew K. Iyer

    (Michigan Center for Translational Pathology, University of Michigan Medical School)

  • Xiaojun Jing

    (Michigan Center for Translational Pathology, University of Michigan Medical School)

  • Yi-Mi Wu

    (Michigan Center for Translational Pathology, University of Michigan Medical School
    University of Michigan Medical School)

  • Xuhong Cao

    (Michigan Center for Translational Pathology, University of Michigan Medical School
    Howard Hughes Medical Institute, University of Michigan Medical School)

  • Zhaohui S. Qin

    (Emory University)

  • Shaomeng Wang

    (Pharmacology, and Medicinal Chemistry, University of Michigan Medical School
    Comprehensive Cancer Center, University of Michigan Medical School)

  • Felix Y. Feng

    (Michigan Center for Translational Pathology, University of Michigan Medical School
    University of Michigan Medical School
    Comprehensive Cancer Center, University of Michigan Medical School)

  • Arul M. Chinnaiyan

    (Michigan Center for Translational Pathology, University of Michigan Medical School
    University of Michigan Medical School
    Howard Hughes Medical Institute, University of Michigan Medical School
    Comprehensive Cancer Center, University of Michigan Medical School)

Abstract

Small-molecule compounds that target the BET domain in proteins such as BRD4 have recently been identified as potential anticancer agents; here, the efficacy of the BRD4-targeting compound JQ1 is demonstrated in castration-resistant prostate cancer driven by deregulated androgen receptor action.

Suggested Citation

  • Irfan A. Asangani & Vijaya L. Dommeti & Xiaoju Wang & Rohit Malik & Marcin Cieslik & Rendong Yang & June Escara-Wilke & Kari Wilder-Romans & Sudheer Dhanireddy & Carl Engelke & Mathew K. Iyer & Xiaoju, 2014. "Therapeutic targeting of BET bromodomain proteins in castration-resistant prostate cancer," Nature, Nature, vol. 510(7504), pages 278-282, June.
    • Handle: RePEc:nat:nature:v:510:y:2014:i:7504:d:10.1038_nature13229
    DOI: 10.1038/nature13229
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/nature13229
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.
    File URL: https://libkey.io/10.1038/nature13229?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Reyaz ur Rasool & Caitlin M. O’Connor & Chandan Kanta Das & Mohammed Alhusayan & Brijesh Kumar Verma & Sehbanul Islam & Ingrid E. Frohner & Qu Deng & Erick Mitchell-Velasquez & Jaya Sangodkar & Aqila , 2023. "Loss of LCMT1 and biased protein phosphatase 2A heterotrimerization drive prostate cancer progression and therapy resistance," Nature Communications, Nature, vol. 14(1), pages 1-24, December.
    2. Zhao Wei & Song Wang & Yaning Xu & Wenzheng Wang & Fraser Soares & Musaddeque Ahmed & Ping Su & Tingting Wang & Elias Orouji & Xin Xu & Yong Zeng & Sujun Chen & Xiaoyu Liu & Tianwei Jia & Zhaojian Liu, 2023. "MYC reshapes CTCF-mediated chromatin architecture in prostate cancer," Nature Communications, Nature, vol. 14(1), pages 1-15, December.
    3. Donglin Ding & Rongbin Zheng & Ye Tian & Rafael Jimenez & Xiaonan Hou & Saravut J. Weroha & Liguo Wang & Lei Shi & Haojie Huang, 2022. "Retinoblastoma protein as an intrinsic BRD4 inhibitor modulates small molecule BET inhibitor sensitivity in cancer," Nature Communications, Nature, vol. 13(1), pages 1-15, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:510:y:2014:i:7504:d:10.1038_nature13229. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.